lincomycin and cefotaxime
lincomycin has been researched along with cefotaxime in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
| Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
| Dorić, M; Vucković, D | 1 |
| Chaimanee, P; Kosalaraksa, P; Lumbiganon, P; Surakunprapha, P | 1 |
Reviews
1 review(s) available for lincomycin and cefotaxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
7 other study(ies) available for lincomycin and cefotaxime
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Changes in macrophage function during chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Biopterins; Cefotaxime; Ceftazidime; Cell Adhesion; Cell Movement; Female; Interferon-gamma; Lincomycin; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred Strains; Neopterin; Penicillin G; Streptomycin | 1997 |
Post operative penicillin-non-susceptible Streptococcus pneumoniae meningitis and septic shock in a child.
Topics: Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Drug Resistance, Bacterial; Female; Humans; Infant; Lincomycin; Meningoencephalitis; Pneumonia, Staphylococcal; Postoperative Complications; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |